Waldemar Lernhardt

San Diego, CA (USA)
Role(s):
C-Level Executive (CEO, CFO, etc.)

Proveri Inc

Location: San Diego
Industry: Healthcare
Year Founded: 2004
Number Employees: 1-10 people
Business Stage: Growth (not profitable)
Entity Type: "C" Corporation
Description: Proveri Inc. is developing new diagnostic and prognostic tests to clearly establish the presence or absence of prostate cancer in biopsies of men suspected of having prostate cancer. We are combining clinically validated cancer biomarkers with digital tissue imaging technology to provide urologists and pathologists with cost-saving tools for improved decision making regarding cancer treatment options. We have been financed by founders, angel investors and an SBIR grant from the National Cancer Institute. We are seeking USD 500k bridge financing to provide additional runway to a USD 7 million Series A financing. Time to product launch in a CLIA lab setting is 24 months. Exit will be though acquisition by large pathology services company in 3 - 5 years.